Estimated Impact of US Preventive Services Task Force Recommendations on Use and Cost of Statins for Cardiovascular Disease Prevention Quyen Ngo-Metzger, MD, MPH, Samuel H. Zuvekas, PhD, and Arlene S. Bierman, MD, MS Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Rockville, MD, USA. healthcare costs. Future research will determine whether BACKGROUND: US Preventive Services Task Force the USPSTF’s recommendations will result in similar (USPSTF) released new recommendations on statin use findings. for atherosclerotic cardiovascular disease (ASCVD) pre- vention. The Affordable Care Act (ACA) mandates USPSTF KEY WORDS: prevention; statin; cholesterol; cardiovascular; cost. recommendations with an BA^ or BB^ grade receive insur- ance coverage without copayment. We assessed the po- J Gen Intern Med 33(8):1317–23 tential impact of these recommendations. DOI: 10.1007/s11606-018-4497-4 OBJECTIVE: To assess the US population meeting crite- © Society of General Internal Medicine (This is a U.S. Government work and not ria for statin use and factors associated with use, and undercopyright protectionintheUS; foreigncopyrightprotectionmay apply)2018 calculate associated costs. DESIGN AND MEASURES: We estimated 10-year ASCVD event risk scores from National Health and Nutrition Ex- amination Survey data using Pooled Cohort Equations INTRODUCTION from the American College of Cardiology/American Heart Association and
Journal of General Internal Medicine – Springer Journals
Published: May 31, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera